This subnnlsslon is in response to CAI 0-503 Comprehensive Partnerships to Reduce Cancer Health Disparities. This application, submitted by the Dana-Farber/Harvard Cancer Center and its partner UMASSBoston, describes plans to transition the successful U56 Partnership to a U54. From its inception, the Partnership has been based on strong institutional support, significant personal commitment of the leadership, and a belief in the institutional benefit that would be derived from a successful partnership. Two key tenets underlie the formation of our Partnership: a) a common and intense interest in addressing the problem of racial, ethnic, and socioeconomic disparities in cancer;and b) a belief that through the partnership, each partner will achieve benefits that neither could achieve on its own. Through careful planning, a mature, solid, and committed partnership has evolved which has been transformative for both institutions. This application provides extensive evidence of the ways these tenets have been operationalized and the resulting benefits, which have been substantial for both institutional partners. In addition to robust Administrative and Planning &Evaluation Cores, and two shared resources (Training Core and Statistical and Survey Methods Core), the application includes rigorous and innovative science, representing basic, clinical, and population science, as well as an innovative post-doctoral training program in nursing and health disparities. The Partnership has strong and enthusiastic personal and institutional support from the leaders of the respective institutions. The Partnership has well-established communication, leadership, and evaluation in place, and Is guided by an outstanding, external Program Steering Committee. This Partnership is fully prepared to move to the U54 mechanism.

Public Health Relevance

This strong and stable Partnership has an excellent track record of developing cancer-focused research activities at the Minority Serving Institution, strengthening the cancer disparities and outreach research programs at the Comprehensive Cancer Center, and conducting robust student training programs. The Partnership is well-positioned to transition to a U54.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54CA156734-05S1
Application #
8871986
Study Section
Special Emphasis Panel (ZCA1-SRLB-3 (O1))
Program Officer
Moten, Carmen P
Project Start
2010-09-28
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
$107,853
Indirect Cost
$37,130
Name
University of Massachusetts Boston
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
808008122
City
Boston
State
MA
Country
United States
Zip Code
02125
Kulkarni, Prajna R; Jia, Tao; Kuehne, Sarah A et al. (2014) A sequence-based approach for prediction of CsrA/RsmA targets in bacteria with experimental validation in Pseudomonas aeruginosa. Nucleic Acids Res 42:6811-25
Frenette, Mathieu; Hatamimoslehabadi, Maryam; Bellinger-Buckley, Stephanie et al. (2014) Nonlinear optical properties of multipyrrole dyes. Chem Phys Lett 608:303-307
Veraksa, Alexey (2013) Regulation of developmental processes: insights from mass spectrometry-based proteomics. Wiley Interdiscip Rev Dev Biol 2:723-34
Kulkarni, Prakash; Shiraishi, Takumi; Kulkarni, Rahul V (2013) Cancer: tilting at windmills? Mol Cancer 12:108
Zhu, Jian; Larman, H Benjamin; Gao, Geng et al. (2013) Protein interaction discovery using parallel analysis of translated ORFs (PLATO). Nat Biotechnol 31:331-4
Degoutin, Joffrey L; Milton, Claire C; Yu, Eefang et al. (2013) Riquiqui and minibrain are regulators of the hippo pathway downstream of Dachsous. Nat Cell Biol 15:1176-85